STOCK TITAN
  1. Home
  2. Sec-filings
  3. APVO
  4. [EFFECT] Aptevo Therapeutics Inc SEC Filing

[EFFECT] Aptevo Therapeutics Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 18, 2025 9:00 A.M.
Form: S-1
CIK: 0001671584
Company Name: Aptevo Therapeutics Inc.
File Number: 333-288061

Source: View Original Filing on SEC EDGAR

Stock APVO logo
Aptevo Therapeutics Inc

NASDAQ:APVO

APVO Rankings

#6492 Ranked by Market Cap
N/A Ranked by Dividends

APVO Latest News

Sep 16, 2025
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
Sep 4, 2025
Aptevo Unveils Two Next-Generation, Industry Leading Trispecifics, Expanding CD3 Oncology Pipeline to Five Molecules
Aug 13, 2025
Aptevo Highlights APVO442, a CD3-Directed Preclinical Candidate for Prostate Cancer
Aug 11, 2025
Aptevo Therapeutics Reports 2Q25 Financial Results And Provides A Business Update
Jun 20, 2025
Aptevo Therapeutics Announces Closing of $8 Million Offering Priced At-the-Market Under Nasdaq Rules

APVO Latest SEC Filings

Oct 3, 2025
[Form 4] BANK OF AMERICA CORP /DE/ Insider Trading Activity
Oct 3, 2025
[Form 4] BANK OF AMERICA CORP /DE/ Insider Trading Activity
Oct 3, 2025
[Form 3] BANK OF AMERICA CORP /DE/ Initial Statement of Beneficial Ownership
Oct 3, 2025
[Form 3] BANK OF AMERICA CORP /DE/ Initial Statement of Beneficial Ownership
Sep 16, 2025
[8-K] Aptevo Therapeutics Inc. Reports Material Event

APVO Stock Data

4.77M
13.81M
0%
0.48%
3.11%
Biotechnology
Pharmaceutical Preparations
Link
United States
SEATTLE